Kunio Matsumoto researcher
Matsumoto, Kunio
松本, 邦夫, 1959-
Matsumoto, Kunio 1959-....
마쓰모토 구니오 1959-
松本, 邦夫
Kunio, Matsumoto
VIAF ID: 36149106160668491212 (Personal)
Permalink: http://viaf.org/viaf/36149106160668491212
Preferred Forms
- 100 0 _ ‡a Kunio Matsumoto ‡c researcher
-
- 200 _ | ‡a Matsumoto ‡b Kunio ‡f 1959-....
- 100 1 _ ‡a Matsumoto, Kunio
-
- 100 1 _ ‡a Matsumoto, Kunio
-
-
- 100 1 _ ‡a 松本, 邦夫
- 100 1 _ ‡a 松本, 邦夫 ‡d 1959-
- 100 1 _ ‡a 松本, 邦夫, ‡d 1959-
- 100 1 _ ‡a 마쓰모토 구니오 ‡d 1959-
4xx's: Alternate Name Forms (21)
Works
Title | Sources |
---|---|
Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation. | |
Growth factors and their receptors in cancer metastasis | |
Growth factors : cell growth, morphogenesis, and transformation | |
Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. | |
Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4. | |
Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. | |
Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors. | |
Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. | |
Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats | |
Hepatocyte growth factor/MET in cancer progression and biomarker discovery | |
Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. | |
Hepatocyte growth factor prevents pulmonary ischemia-reperfusion injury in mice | |
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. | |
Hepatocyte growth factor promotes the number of PSD-95 clusters in young hippocampal neurons | |
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. | |
HGF no bunshi igaku : Byōtai seiri shindan chiryō | |
The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. | |
HGFの分子医学 : 病態生理・診断・治療 | |
HGFタリングルによる血管抑制と新規タリングル分子の同定・血管調節に関する研究 | |
hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells. | |
Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. | |
Impaired ligand-dependent MET activation caused by an extracellular SEMA domain missense mutation in lung cancer | |
In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. | |
Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model. | |
Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor. | |
Interruption of the HGF paracrine loop by NK4, an HGF antagonist, reduces VEGF expression of CT26 cells. | |
Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1. | |
Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland | |
Lack of association between the hepatocyte growth factor receptor, c-met, and the anti-apoptotic action of bag-1 in endothelial cells. | |
Liver organogenesis promoted by endothelial cells prior to vascular function. | |
Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model | |
Mechanisms and significance of bifunctional NK4 in cancer treatment. | |
MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner | |
Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes. | |
mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF. | |
N-glycosylation regulates MET processing and signaling | |
NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor. | |
NK4 gene therapy targeting HGF-Met and angiogenesis. | |
No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice. | |
Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases | |
Novel long-acting prostacyclin agonist (ONO-1301) with an angiogenic effect: promoting synthesis of hepatocyte growth factor and increasing cyclic AMP concentration via IP-receptor signaling. | |
The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor. | |
Oceanographic data of the 21st Japanese Antarctic Research Expedition from November 1979 to April 1980 | |
Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. | |
Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells. | |
Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury | |
Possible effects of hepatocyte growth factor for the prevention of peritoneal fibrosis | |
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion | |
The protective effect of hepatocyte growth factor against cell death in the hippocampus after transient forebrain ischemia is related to the improvement of apurinic/apyrimidinic endonuclease/redox factor-1 level and inhibition of NADPH oxidase activ | |
Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. | |
Recombinant human hepatocyte growth factor (HGF), but not rat HGF, elicits glomerular injury and albuminuria in normal rats via an immune complex-dependent mechanism. | |
Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects. | |
Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. | |
Regulation of cell migration and cytokine production by HGF-like protein (HLP) / macrophage stimulating protein (MSP) in primary microglia. | |
Renotropic role and therapeutic potential of HGF in the kidney | |
Repair of segmental bone defects in rabbit tibia promoted by a complex of β-tricalcium phosphate and hepatocyte growth factor | |
Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides. | |
Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy | |
Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice | |
Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. | |
Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model | |
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. | |
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer | |
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer. | |
Treatment of dilated cardiomyopathy with electroporation of hepatocyte growth factor gene into skeletal muscle. | |
Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas. | |
Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells. | |
Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy. | |
傷害察知と連携したMet/HGF受容体シグナル変換能の調節を介した再生制御の研究 | |
細胞増殖因子と再生医療 = Growth factor & regenerative medicine | |
肝障害に伴うHGF(肝細胞増殖因子)の発現誘導と発現誘導因子の実体解明 | |
難治性臓器疾患に対するHGF(肝細胞増殖因子)の抗線維化機構の解析と治療への応用 |